Bristol-Myers Squibb Co has shown strong financial performance and innovation in drug development, especially in immuno-oncology. Despite U.S. market dependence and patent challenges, global expansion and strategic partnerships offer growth opportunities. The company faces competition and regulatory risks in the pharmaceutical industry.